{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:51:01Z","timestamp":1767919861959,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.tmaid.2015.04.005","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T18:30:16Z","timestamp":1430591416000},"page":"400-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Eye disorders reported with the use of mefloquine (Lariam\u00ae) chemoprophylaxis \u2013 A drug safety database analysis"],"prefix":"10.1016","volume":"13","author":[{"given":"Miriam","family":"Adamcova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin T.","family":"Schaerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Bercaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain","family":"Cockburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Georg","family":"Rhein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Schlagenhauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.tmaid.2015.04.005_bib1","doi-asserted-by":"crossref","first-page":"790","DOI":"10.4269\/ajtmh.2006.75.790","article-title":"Malarial retinopathy: a newly established diagnostic sign in severe malaria","volume":"75","author":"Beare","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2015.04.005_bib2","first-page":"150","article-title":"Falciparum malaria induced retrobulbar neuritis","volume":"50","author":"Kale","year":"2004","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.tmaid.2015.04.005_bib3","first-page":"479","article-title":"Optic neuritis after meningococcal vaccination","volume":"81","author":"Laria","year":"2006","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"4","key":"10.1016\/j.tmaid.2015.04.005_bib4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/CMR.13.4.662","article-title":"Fungal and parasitic infections of the eye","volume":"13","author":"Klotz","year":"2000","journal-title":"Clin Microbiol"},{"issue":"5","key":"10.1016\/j.tmaid.2015.04.005_bib5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/archopht.126.5.644","article-title":"High incidence of optic disc swelling at very high altitudes","volume":"126","author":"Bosch","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.tmaid.2015.04.005_bib6","first-page":"184","article-title":"New insights into changes in corneal thickness in healthy mountaineers during a very-high-altitude climb to Mount Muztagh Ata","volume":"128","author":"Bosch","year":"2010","journal-title":"ArchOphthalmol"},{"key":"10.1016\/j.tmaid.2015.04.005_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tmaid.2013.03.009","article-title":"Eye problems on expeditions","volume":"11","author":"Morris","year":"2013","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2015.04.005_bib8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4414\/fms.2006.06017","article-title":"High altitude retinopathy","volume":"6","author":"Schnetzler","year":"2006","journal-title":"Forum Med Suisse"},{"issue":"11","key":"10.1016\/j.tmaid.2015.04.005_bib9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s12325-010-0065-y","article-title":"Jet lag, circadian rhytm sleep disturbances, and depression: the role of melatonin and its analogs","volume":"27","author":"Srinivasan","year":"2010","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.tmaid.2015.04.005_bib10","article-title":"Visual hallucinations: differential diagnosis and treatment","volume":"11","author":"Teeple","year":"2009","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.tmaid.2015.04.005_bib11","unstructured":"Long J, Irish National Documentation Centre on Drug Use: http:\/\/www.drugsandalcohol.ie\/14692\/."},{"issue":"5\u20136","key":"10.1016\/j.tmaid.2015.04.005_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tmaid.2012.09.004","article-title":"Demographics, health and travel characteristics of international travellers at a pre-travel clinic in Marseille, France","volume":"10","author":"Aubry","year":"2012","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2015.04.005_bib13","first-page":"237","article-title":"Long term case of antimalarial toxicity after cessation of treatment","volume":"27","author":"Easterbrook","year":"1992","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.tmaid.2015.04.005_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"American academy of ophthalmology: revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.tmaid.2015.04.005_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3129\/can.j.ophthalmol.06-093","article-title":"Maculopathy associated with mefloquine (Lariam) therapy for malaria prophylaxis","volume":"42","author":"Walker","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.tmaid.2015.04.005_bib16","series-title":"Clinical ocular pharmacology","author":"Barlett","year":"2001"},{"key":"10.1016\/j.tmaid.2015.04.005_bib17","unstructured":"http:\/\/www.cioms.ch\/publications\/reporting_adverse_drug.pdf."},{"issue":"1","key":"10.1016\/j.tmaid.2015.04.005_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tmaid.2013.07.007","article-title":"Use of anti-malarial drugs and the risk of developing eye disorders","volume":"12","author":"Schneider","year":"2014","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2015.04.005_bib19","series-title":"A Medwatch continuing education article, staff college, Center for Drug Evaluation and Research, Food and Drug Administration","author":"Goldman","year":"1996"},{"key":"10.1016\/j.tmaid.2015.04.005_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1475-2875-9-357","article-title":"The position of mefloquine as a 21st century malaria prophylaxis","volume":"9","author":"Schlagenhauf","year":"2010","journal-title":"Malar J"},{"issue":"33","key":"10.1016\/j.tmaid.2015.04.005_bib21","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0402044101","article-title":"Potent block of Cx36 and Cx50 gap junction channels by mefloquine","volume":"101","author":"Cruikshank","year":"2004","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.tmaid.2015.04.005_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00232-006-0021-6","article-title":"Mefloquine effects on the lens suggest cooparative gating of gap junction channels","volume":"211","author":"Martinez-Wittinghan","year":"2006","journal-title":"J Membr Biol"},{"issue":"4","key":"10.1016\/j.tmaid.2015.04.005_bib23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1708-8305.2008.00222.x","article-title":"Narrow vision after view-broadening travel","volume":"15","author":"De Mendonca Melo","year":"2008","journal-title":"J Travel Med"},{"issue":"4","key":"10.1016\/j.tmaid.2015.04.005_bib24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1708-8305.2007.00122.x","article-title":"Malaria and mefloquine prophylaxis use among Japan Ground Self-Defence Force personnel deployed in East Timor","volume":"14","author":"Fujii","year":"2007","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2015.04.005_bib25","series-title":"Clinical ophthalmology, a systematic approach","author":"Kanski","year":"2006"},{"key":"10.1016\/j.tmaid.2015.04.005_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrneurol.2010.5","article-title":"The optic nerve head in acquired optic neuropathies","volume":"6","author":"O'Neill","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"10.1016\/j.tmaid.2015.04.005_bib27","first-page":"492","article-title":"The side effects of corticosteroids","volume":"3","author":"Becker","year":"1964","journal-title":"Investig Ophthalmol"},{"key":"10.1016\/j.tmaid.2015.04.005_bib28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/bjo.82.5.538","article-title":"Oral contraception and eye disease: findings in two large cohort studies","volume":"82","author":"Vessey","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.tmaid.2015.04.005_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/0973-1482.73332","article-title":"Crystaline maculopathy: a rare complication of tamoxifen therapy","volume":"6","author":"Srikantia","year":"2010","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.tmaid.2015.04.005_bib30","series-title":"Ophthalmology","author":"Yanoff","year":"1999"},{"issue":"4","key":"10.1016\/j.tmaid.2015.04.005_bib31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1590\/S0004-27492010000400019","article-title":"Ocular complications of chloroquine and derivatives therapy","volume":"73","author":"Lacava","year":"2010","journal-title":"Arg Bras Oftalmol"},{"key":"10.1016\/j.tmaid.2015.04.005_bib32","article-title":"Basic and clinical science Course","volume":"12","author":"American Academy of Ophthalmology","year":"2005","journal-title":"Retina Vitreous Sect"},{"issue":"1","key":"10.1016\/j.tmaid.2015.04.005_bib33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00003495-200767010-00006","article-title":"Ocular adverse effects associated with systemic medications: recognition and management","volume":"67","author":"Santaella","year":"2007","journal-title":"Drugs"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893915000769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893915000769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:00:50Z","timestamp":1761487250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893915000769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1477893915000769"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2015.04.005","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eye disorders reported with the use of mefloquine (Lariam\u00ae) chemoprophylaxis \u2013 A drug safety database analysis","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2015.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}